ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Internal Medicine

Top Internal Medicine Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RAHWA GHERMAY M.D

Internal Medicine

811

$56.7K

133
79 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 26%

$70
Average prescription price

Avg: $56

KURT KANG M.D.

Internal Medicine

793

$39.7K

76
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $56

JASPAL GUJRAL MD

Internal Medicine

789

$73.3K

91
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 26%

$93
Average prescription price

Avg: $56

WILLIAM GROW M.D.

Internal Medicine

788

$230K

333
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

64%
prescriptions for brand name drugs

Avg: 26%

$292
Average prescription price

Avg: $56

JOHN ROWLETT MD

Internal Medicine

786

$11.6K

457
243 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

33%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

7%
prescriptions for brand name drugs

Avg: 26%

$15
Average prescription price

Avg: $56

MICHAEL KINSTLER M.D.

Internal Medicine

775

$32.5K

87
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$42
Average prescription price

Avg: $56

SANDRA FRYHOFER MD

Internal Medicine

770

$61.1K

53
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 26%

$79
Average prescription price

Avg: $56

BRICK ACOSTA M.D.

Internal Medicine

767

$36.6K

169
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

JOANNA BONSALL M.D., PH.D.

Internal Medicine

756

$44.7K

48
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 26%

$59
Average prescription price

Avg: $56

SUNITHA KALUVEHALLIMATTA MBBS

Internal Medicine

754

$30.3K

69
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$40
Average prescription price

Avg: $56

SYED BABER M.D., PHD

Internal Medicine

742

$61.4K

61
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$83
Average prescription price

Avg: $56

MYRTLE WILDER CNP

Internal Medicine

734

$36.9K

62
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $56

CLAUDE SANKS M.D.

Internal Medicine

731

$33.8K

72
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $56

MARK MCCRACKEN MD

Internal Medicine

725

$36.8K

239
158 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $56

NEIL WINAWER M.D.

Internal Medicine

725

$59.9K

121
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 26%

$83
Average prescription price

Avg: $56

MILICA BETZ MD

Internal Medicine

721

$35.9K

205
168 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $56

SWAINSBORO MEDICAL CLINIC P.C.

Internal Medicine

714

$38.4K

15
13 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $56

SAGAR SHROFF M.D.

Internal Medicine

713

$36.4K

89
37 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $56

CHRISTINA HENDRY M.D

Internal Medicine

710

$34.1K

68
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

FREHIYWOT AYELE

Internal Medicine

701

$25K

110
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 26%

$36
Average prescription price

Avg: $56

ROBERTO GARCIA MD

Internal Medicine

696

$31.2K

180
102 are 65+

16%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 26%

$45
Average prescription price

Avg: $56

JOHN SHANER M.D.

Internal Medicine

694

$26.1K

104
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$38
Average prescription price

Avg: $56

SYLVANUS FIAKPORNOO MD

Internal Medicine

688

$28.7K

187
122 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 26%

$42
Average prescription price

Avg: $56

ALEXANDR BABAYEUSKI MD

Internal Medicine

686

$30K

131
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $56

ELLA GILLESPIE MD

Internal Medicine

683

$51.8K

140
110 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 26%

$76
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank